Abstract. Monoclonal antibodies (mAbs) have been produced against the chicken/3, subunit that affect integrin functions, including ligand binding, ot subunit association, and regulation of ligand specificity. Epitope mapping of these antibodies was used to identify regions of the subunit involved in these functions. To accomplish this, we produced mouse/chicken chimeric 81 subunits and expressed them in mouse 3T3 cells. These chimeric subunits were fully functional with respect to heterodimer formation, cell surface expression, and cell adhesion. They differed in their ability to react with a panel of anti-chicken/~l mAbs. Epitopes were identified by a loss of antibody binding upon substitution of regions of the chicken/3, subunit by homologous regions of the mouse/31 subunit. The identification of the epitope was confirmed by a reciprocal exchange of chicken and mouse fit domains that resulted in the gain of the ability of the mouse subunit to interact with a particular anti-chicken/31 mAb. Using this approach, we found that the epitopes for one set of antibodies that block ligand binding mapped toward the amino terminal region of the/31 subunit. This region is homologous to a portion of the ligand-binding domain of the/~3 subunit. In addition, a second set of antibodies that either block ligand binding, alter ligand specificity, or induce a//3 subunit dissociation mapped to the cysteine rich repeats near the transmembrane domain of the molecule. These data are consistent with a model in which a portion of/31 ligand binding domain rests within the amino terminal 200 amino acids and a regulatory domain, that affects ligand binding through secondary changes in the structure of the molecule resides in a region of the subunit, possibly including the cysteine-rich repeats, nearer the transmembrane domain. The data also suggest the possibility that the ot subunit may exert an influence on ligand specificity by interacting with this regulatory domain of the/31 subunit.
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T
HF. integrins represent a family of receptors involved in both cell-matrix and cell-cell adhesion Hemler, 1990; Hynes, 1992) . They are heterodimers consisting of an ot subunit non-covalently associated with a /3 subunit. Currently, 14 different a subunits and 8 different/~ subunits (not including alternatively spliced forms) have been described. They join in different combinations to form the 20 integrins presently recognized in vertebrates. Each heterodimer forms a transmembrane complex, its extracellular domain interacting with a ligand and its cytoplasmic domain interacting with elements of the cytoskeleton. Integrin-ligand interactions also serve to generate intraceUular signals that result in cytoplasmic alkalinization (Schwartz et al., 1991) , protein phosphorylation (Guan et al., 1991; Kornberg et al., 1991; Guan and Shalloway, 1992) , changes in calcium influx (Ng-Sikorski et Please address all correspondence to Dr. Clayton A. Buck, Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. al., 1991; Pardi et al., 1989) , and cell proliferation (Shimizu et al., 1990) . In addition, integrin responses to second messages result in changes ofligand specificity or affinity (Shattil et al., 1985; Tanaka et al., 1992; Thornhill et al., 1991) . Ligand binding and receptor activation are accompanied by conformational changes in integrins that result in new mAb binding sites and increased ligand affinity (Coller, 1985; Frelinger et al., 1990 Frelinger et al., , 1991 Altieri and Edgington, 1988; Duet al., 1991) . Thus integrins bind ligands, respond to intracellular and extracellular signals, coordinate cytoskeleton-membrane interactions, and transmit information into the cell resulting in changes in cell morphology and function (for review see Hynes, 1992) .
To identify regions of the Bt subunit that may be involved in several of these functions, we have mapped the epitopes of a panel of chicken fit-specific mAbs that interfere with a particular integrin function using a series of mouse/chicken chimeric subunits. The reagents employed in these studies include mAbs that perturb cell-substratum interactions, disrupt subunit association, or affect substratum specificity. Among the antibodies that perturb cell substratum interactions are CSAT (Neff et al., 1982) and JG22 (Greve and Gottlieb, 1982), both of which have been extensively characterized. It is assumed that these antibodies interact with regions of the receptor involved in ligand binding. Another antibody, TASC (Neugebauer and Reichardt, 1991) , has the ability to block the binding of neuronal cells to vitronectin, and also to stimulate their adherence to laminin. This antibody is assumed, therefore, to interact with regulatory domains of the integrin/3~ subunit.
Our results demonstrate that ligand-binding activity is blocked by mAbs that recognize epitopes widely separated on a linear amino acid map, and that there exist both ligand binding and regulatory regions that are distinct from one another.
Materials and Methods

Chimeric Plasmid Construction
We have previously described the construction and expression of the full length cDNA clone for chicken/~l, pCINT/~RV (Solowska et al., 1991) . The chicken/31 cDNA was also cloned into the EcoRI site of the expression vector, pCMV-5 (Anderson et al., 1988) , provided by Drs. Gary Cohen and Rosalyn Eisenberg of the University of Pennsylvania (Philadelphia, PA), that had been modified to eliminate the cloning sites between Kpn I and Sma I. The resulting expression plasmid was designated pCMV-5CINT/~IRV. A 3.6-kb Hind HI cDNA fragment containing most ofthe coding region of the mouse/31 subunit in Bluescript (pBSM/~0 was kindly provided by Dr. V. Michael Hollers of Washington University (St. Louis, MO).
PCR-directed mutagenesis and PCR-driven splice overlap extension (SOE) l (Horton et al., 1990) were used to generate five chimeric mouse/chicken ~1 expression plasmids, designated MC-1 through MC-5, as described below. PCR reactions were performed in an automatic thermal cycler (Perkin-Elmer Cetus Instrs., Norwalk, CT). Each 100/~1 reaction mixture included 10 mM Tris-HCl, pH 8.0, 1.5 mM MgCl2, 50 mM KC1, 0.1% gelatin, 10% DMSO, 0.06% 2-mercaptoethanol, 200 mM each dNTP and 2.5 U of Taq DNA polymerase (Perkin-Elmer Cetus Instrs.). Reactions were cycled 25 times through a program that included incubations at 94°C for 1 rain, 56°C for 1 min, and 72°C for 2 rain.
The primers used in the construction of each of the mouse/chicken chimeric cDNAs are shown in Table I .
Construction of MCI. Primers were designed to amplify the mouse E1
subunit from bp 1 to bp 627 and contained Stu I (sense primer) and Asu
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SOE, splice overlap extension. II (antisense primer) sites at their 5' ends. Because pBSM/~I did not contaln 395 bp of the 5' coding region, we used reverse mmscription-PCR (RT-PCR) to amplify this fragment. Total cellular RNA was isolated from 3"1"3 cells by sequential extraction in RNAzol (Biotecx, Houston, TX) and chloroform, followed by isopropanol precipitation. 5 #g of total RNA was subjected to RT-PCR using the cDNA Cycle Kit (Invitrogen, San Diego, CA) according to the manufacturer's directions. First strand synthesis was accomplished using random primers and reverse transcriptase. This strand was used as template in the standard PCR reaction. The RT-PCR product was gel purified using Gene Clean II glass beads (Bio !01) according to the manufacturer's directions and cut with Stu I and Asu II. pCINT~rRV was cut with Stu I and Asu 1I. The large piece of these digestion products was purified and ligated with the murine cDNA obtained above to yield the plasmid pMC1.
Construction OfMC2. PCR primers were designed to amplify the region of mouse/~t from bp 627 to bp 1077 of the cDNA and contained Asu II (sense primer) and Hind Ill (antisense primer) restriction sites at their 5' ends. Amplified DNA product was separated on a 1.0% agarose gel, visualized by ethidium bromide, purified, and digested with Asu II and Hind M. pCINT~tRV was cut with Asu II and Hind m and the digestion products were separated on an agarose gel, and the larger piece was cut out and purified. This larger piece was then ligated with the amplified mouse ~1 cDNA fragment. The resulting plasmid was designated pMC2.
Construction of MC3. Primers were designed to amplify the region of mouse ~t from bp 1077 to 1967 from the cDNA and contained Hind m (sense primer) and BamI-I I (antisense primer) sites near their 5' ends. PCR product was purified and cut with Hind M and BamH I. pCMV-5CINT/~IRV cut with Hind m and BamH I was resolved on an agarose gel. The larger piece was purified and ligated with the mouse sequence obtained above. The resulting plasmid was designated pMC3.
Construction of MC4. The plasmids pMC2 and pBSM/~I were digested with Tthlll I and Xho I and resolved on an agarose gel. The larger fragments from both digests were purified and ligated together. The resulting plasmid was designated pMC4.
Construction OfMCS. PCR primers were designed to amplify the mouse ~1 subunit from bp 627 to 1631 using mouse cDNA template and included an Asu II site at the 5' end of the sense primer. Additional primers were designed to amplify the chicken ~1 subunit from bp 1642 to 1980 using the chicken cDNA as template and included a BamI-I I site at the 5' end of the antisense primer. The mouse/~1 antisense and the chicken ~1 sense primers corresponded to a region that was identical between the species and were complementary to each other. The amplified mouse and chicken cDNA fragments were mixed together and subjected to a further round of SOE in the presence of the mouse sense and chicken antisens¢ primers. The resulting spliced mouse/chicken cDNA was cut with Asu II and BamH I and gel purified. The coding sequence between Asu H and BamH I of pMC1 was cut out and replaced with the spliced cDNA to yield the plasmid pMC5.
Confirmation of Chimeric cDNA Sequence. The chimeric nature of each construct was confirmed by PCR amplification using one mousespecific and one chicken-specific primer. Constructs were also sequenced across the chimeric junction by the dideoxy nucleotide method to further validate the nature of the insert.
Transfection of 3T3 Cells
NIH 3T3 cells maintained in DMEM with 10% FBS were transfected as described previously (Solowsks ct ai., 1989) . Briefly, cells (105) plated the previous day in 100-ram dishes were cotranst~cted with 10/~g of each chimeric construct plasmid, 2 ~,g of pSV2-neo and 10/~g of salmon sperm DNA as a calcium phosphate precipitate. After two days, the cells were split 1:15 into DMEM with 10% FBS and 1 mg/ml Geneticin (00418, GIBCO BRL, Gaithersburg, MD). Approximately 2 wk later, G418 resistant clones were picked and screened for expression of the mouse/chicken chimeric B1 subunit by immunoblot assay using the chicken specific polyclonai antibody, Chickie (see below). The positive clones were further enriched by limited dilution subcloning and one clone of each construct was used for further characterization.
Protein Labeling
Cells were metabolically labeled by growing them overnight in methioninefree media supplemented with 250 t~Ci [35S]methionine. Alternatively, cell-surface proteins were labeled with biotin. Briefly, confluent "I"25 flasks were washed with biotin washing buffer (50 mM Tris-HC1, pH 7.5, 150 mM NaC1, 1 mM MgCI2, 1 mM CaCI2) three times, and then labeled with 100 t~g/ml NHS-sulfo-biotin (Pierce Chem. Co., Rock_ford, IL) in biotin washing buffer for 30 rain at 37"C with gentle rocking. After labeling, flasks were washed three times in PBS and the cells extracted with non-ionic detergent buffer (10 mM Tris-Acctate, pH 7.5, 0.5% NP-40, 0.5 mM CaC12) containing 2 mM PMSF for 20 rain at 4"C. Cell extracts were clarified by centrifugation at 14,000 g for 20 rain.
Antibodies
The following polyclonai antisera were used: Lennie (L) and anti-GP140 were raised in rabbit and goat, respectively, against WGA affinity-purified extracts of rat L6A myoblasts and have been shown to react with a wide variety of mammalian integrin/3t subunits, but have no reactivity with chicken B1 (Solowska et al., 1991; Knudsen ct al., 1981) . Chickie (Ch) is a polyclonai rabbit antibody raised against the chicken integrin molecule (Damsky et ai., 1985) that has minimal cross reactivity with mammalian integrins.
The following mAbs, each reacting exclusively with the chicken Bl subunit, were used: CSAT (Neff et ai., 1982) , JG22 (Greve and Gottlieb, 1982) , G (Buck et ai., 1986) , 2AI0 (Chu and Grunwaid, 1991), and TASC (Nengebaner and Reichardt, 1991) . The W1B10, V2E9, VSB8, VSF5, V9C3, and WlGll mAbs to the chicken El subunit were prepared from integrius purified on a CSAT mAb column using 11 day chicken embryos. The properties of W1BI0 and V2E9 have been described previously (Hayashi et al., 1990) . Details about the mAbs are listed in Table H .
Immunofluorescence
Cells were plated in DMEM containing 2% FBS onto coverslips coated with human plasma fibronectin (10 t~g/ml). After 24 h, cells were fixed for 20 min with 3 % buffered paraformaldehyde and permeabilized with an icecold solution of 0.15 M NaC1 containing 1% NP-40 for 1 rain. The coverslips were then incubated for 1 h at room temperature with the polyclonal anti-chicken integrin antibody, Ch, and a monoclonal anti-vinculin antibody (Sigma Chem. Co., St. Louis, MO), washed, and stained for 1 h at room temperature with fluoreseein-conjugated goat anti-rabbit IgG and rhodamine-eonjngated goat anti-mouse IgG (Organon Teknica, I/.oekville, MD). The cells were examined using a Zeiss phase-epi-fluorescent microscope with 63 x planachromat oil-immersion lens and photographed using Kodak Tri-X film.
lmmunoprecipitation
For immunoprecipitation, the nonionic detergent cell extracts were preabsorbed with protein A-conjugated Sepharose (Pharmacia LKB Bioteehnology, Piscataway, NJ) for 30 rain at 4°C. One hundred mieroliters of this antigen solution were mixed with 50 #1 of antibody solution containing 1 #g of immunoglobulin for 18 h at 40C. Immune complexes were absorbed to protein A-conjugated Sepharose beads for 1 h at 4"C and were washed five times with a buffer containing 50 mM Tris HCI (pH Z5), 150 mM NaC1, 1% Triton X-100, 5 % deoxycholate, and 0.1% SDS. For sequential immunoprecipitation the beads were suspended in 1% SDS, boiled for 5 rain, and the SDS diluted tenfold with 2.5% NP-40. The resulting released antigen was mixed with antibody and new protein A-Sepharose, and processed as described above. Immunoprecipitated complexes were then eluted in electrophoresis sample buffer (62.5 mM Tris base, 2% SDS, 10% glycerol, pH 6.8) and electrophoresed through 6% polyacrylamide gels. Biotinylated proteins were transferred from the gel to nitrocellulose paper using the Milli- (Neff et al., 1982) JG22 (Greve and Gottlieb, 1982) 2A10 (Chu and Grunwald, 1991) WlB10 (Hayashi et al., 1990) V8B8 (unpublished observations) TASC (Neugebauer and Reichardt, 1991) G (Buck et al., 1986) V2E9 (Hayashi et al., 1990 blot SDE system (Millipore Corp., Bedford, MA) according to the manufacturer's instructions. Biotinylated protein bands were detected by alkaline phosphatase conjugated-streptavidin (GIBCO BRL) using nitro blue tetrazolium and 5-bromo--4-ehloro-3-indolyl phosphate (Sigma Chem. Co.) as substrate.
[35S]methionine-labeled protein containing gels were enhanced, dried, and exposed to X-omat film (Kodak).
Cell Adhesion Assay
Non-tissue culture 96 well plates were coated overnight with laminin (1 #g/well) at 37"C, and then coated with 4% BSA in PBS for 1 h. Cells, labeled with [3H]thymidine 24 h before use were trypsinized, washed three times in serum free DMEM, and plated at 5 × liP cells per well in the presence of specific antibodies. The cells were allowed to adhere for 2 h at 370C. Unattached cells were removed by gentle washing and the remaining cells were collected on a glass fiber filter using the Tomtec 96 well cell harvester. Filters were air dried and counted in a Packard Matrix 96 counter. Percent adherence was determined by dividing the counts remaining by the total counts plated per well, and normalized to the condition of no added antibody. Each value represents the average of at least four different measurements, and is shown with standard error of the mean.
Results
Mouse-Chicken Chimeric [3l cDNAs Encode Chimeric [31 Subunits, Associate with Endogenous Mouse ~ Subunits, and Are Expressed on the Cell Surface
The chimeric/~ subunits used throughout these investigations are schematically represented within each figure (e.g., Fig. 1 A) . In all cases, within the schematic representation, the filled portions represent chicken sequences and open areas represent mouse sequences. The various constructs are designated C for chicken, M for mouse, and MC for mouse/chicken chimera. The accuracy of the cDNA constructs was determined by PCR analysis and sequencing (see Materials and Methods). In each case, the PCR analysis and subsequent sequencing data confirmed the position of the inserted mouse sequences as well as the fact that no changes in nucleotide sequence occurred during the production of the chimeric cDNA (data not shown). Fig. 1 demonstrates the specificity of the anti-chicken/3, serum, the chimeric nature of each product, the association of each chimeric subunit with endogenous mouse ot subunits and the surface expression of each chimeric subunit. Fig. 1 B shows that the chimeric subunits were found on the cell surface in association with mouse ~ subunits. To accomplish this, cell surface proteins were biotinylated, extracted with nonionic detergents, and subjected to immunoprecipitation followed by SDS-PAGE of the immuno complexes. The pair of SDS-PAGE lanes under the mouse schematic (M) shows the results of immunoprecipitating aliquots of an extract from nontransfected 3T3 cells with the anti-mammalian/~t serum (L) and the anti-chicken/~t serum (Ch). The endogenous/~ integrins and accompanying ot subunits were readily identified by the anti-mammalian/~ serum but not by the anti-chicken/~ serum. In contrast, 3T3 cells transfected with full-length chicken ~ cDNA (C) or the three different mouse/chicken chimeric cDNAs (MC1, MC2, and MC3) all contained 110-120 kD B1 subunits that could be recognized by the anti-chicken ~1 serum, plus coprecipitating proteins of ,,o140 kD representing the accompanying endogenous mouse a subunits. Thus, the products of the transfected cDNAs all were recognized by the chicken-specific antiserum, all paired with endogenous mouse ot subunits, and all were found on the cell surface. Fig. 1 Cillustrates the chimeric nature of the protein product of each cDNA. Transfected 3T3 cells were labeled with [35S]methionine and extracted with NP-40. Each extract was first immunoprecipitated with the anti-chicken /3, serum, Ch. The immunoprecipitate was then dissociated with SDS and divided into two portions. One was used directly for SDS-PAGE analysis and the other was reprecipitated with the anti-mammalian/~1 antibody, L. The first set of lanes under the schematic (M) representing endogenous mouse #~, shows a typical immunoprecipitate of integrins from 3T3 cells. There are two non-specific bands noted, one in the vicinity of the 205 kD marker and the other at ,,o8 kD, typical of metabolically labeled extracts. The two bands at 110 and 120 kD represent the immature and fully glycosylated forms of the mouse ~1 subunit. The bands above this represent a mixture of mouse ot subunits including o~3 and o~5 as shown previously (Solowska et al., 1989) . No material was specifically immunoprecipitated from this extract by the anti- 
Chimeric [31 Subunits Localize to Focal Contacts and Promote CeU-Substratum Adhesion
As a test of the functional integrity of the chimeric B~ subunits, we evaluated their ability to localize in adhesive structures and to participate in cell-matrix adhesion. Transfected cells were plated onto coverslips coated with fibronectin, and 24 h later subjected to immunofluorescence analysis using the anti-chicken #t antibody. Fig. 2 shows, that in each case, the chimeric protein was found concentrated in focal contacts at the cell-matrix interface. That these were indeed focal contacts was confirmed by the fact that vinculin was localized to the same structures by double immunofluorescence.
The test for the ability of the chimeric subunits to promote cell adhesion was based upon the resistance of the chickenmouse chimeric subunit to the adhesion disrupting activity of anti-GP 140, a polyclonal anti-mammalian /~ subunit that has been previously used to perturb cell substratum adhesion (Knudsen et al., 1981; Damsky et al., 1982; Sutherland et al., 1988) . A similar assay has been used to demonstrate the ability of chicken ~ subunits to promote adhesion in mammalian cells (Hayashi et al., 1990; Solowska et al., 1991) . For this purpose, cells were plated on dishes coated with laminin in the absence of blocking antibody or in the presence of either anti-GP140, CSAT, or anti-GP140 plus CSAT. The control cells used in this experiment were 3T3 cells transfected with full length chicken 131 cDNA (C) or with cDNA encoding a chicken/31 subunit missing the cytoplasmic domain (AC), and hence unable to promote cell-matrix adhesion, but capable of binding the CSAT rnAb (Solowska et al., 1989) . While CSAT alone had little or no effect on the ability of any of the cells to adhere to laminin, anti-GP 140 reduced adhesion of the AC cells by ,'o90% indicaring that adhesion was mediated by integrins containing the mammalian 131 subunit. In contrast, cells expressing the intact chicken 131 subunit or the chimeric mouse/chicken subunits remained adherent even in the presence of anti-GP 140. Furthermore, exposure of C, MC2, and MC3 cells to both anti-GP 140 and CSAT prevented adhesion of 80-90% of the cells. However, ,x60 % of MC1 cells remained adherent when CSAT was added to anti-GP140, suggesting a loss of the CSAT reactive region in this chimeric subunlt (see Fig.  3 ). Finally, the fact that MC1, MC2, and MC3 remain adherent in the presence of anti-GP140 suggests that the adhesion disrupting epitope recognized by this polyclonal antiserum is absent in all three chimeric subunits. The chicken sequence that is common to these three subunits contains the epitope for another adhesion blocking mAb, WlB10, as shown in Fig. 3 . These results demonstrate that all the chimeric constructs actively promoted the adhesion of the cells to laminin.
The Epitopes for Adhesion Perturbing and Function Altering mAbs Map to Distinct Regions of the [31 Subunit
The epitope mapping presented here takes advantage of the fact that each of the mAbs used reacts only with the chicken /3~ subunit. Therefore, the ability of any of these mAbs to recognize a chimeric mouse/chicken subunit requires the presence of the appropriate chicken peptide sequence folded into its native configuration. Since integrin function is easily disrupted as a result of genetic manipulation of subunit cDNA, the interpretation of these experimental results is dependent upon the functional integrity of the subunit under investigation (for review see Buck et al., 1990) . The above experimental results suggest that the chimeric subunits maintained their functional integrity, and that the failure of any mAb to react with a particular mouse/chicken chimeric subunlt should be due to replacement of the chicken sequence by the homologous mouse sequence, and not due to secondary structural alterations in the chimeric subunit. Therefore, loss of antibody reactivity constitutes evidence that at least a portion of the binding site for the particular mAb in question is within the replaced region of the molecule.
Chimeric constructs were prepared in which chicken sequences were systematically replaced with homologous mouse sequences between residues 1 and 602. The inserted mouse sequences ranged in size from 140 to 300 amino acids. Typical data for four different mAbs are presented in Fig. 3 . Of the four mAbs used here, three disrupt cell substratum adhesion (CSAT, 2A10, and W1B10) and one blocks chicken cell adhesion to vitronectin but promotes adhesion to laminin (TASC). Transfected and control cells were biotinylated, extracted with NP-40, and the extracts immunoprecipitated with each of the mAbs. Immunoprecipitates were analyzed by SDS-PAGE. The SDS-PAGE profile of each construct is shown below its respective schematic presentation. All mAbs grouped together in Fig. 3 gave the same immunoprecipitation profiles, mAbs with no known biological activity are italicized.
Three of the mAbs that block cell substratum adhesion, CSAT, JG22, and V8B8 failed to immunoprecipitate chimeric subunit MC1 in which the first 160 amino acids of the chicken subunit were replaced by the homologous region from the mouse subunit. They did, however, immunoprecipitate each subunit in which the first 160 amino acids was chicken, suggesting that part of the epitope for these antibodies resides in this region of the molecule. 2A10, another adhesion-perturbing mAb, could only precipitate MC3, indicating that the epitope for this mAb resides on both sides of amino acid 160 of the chicken subunit. The fact that both the MC1 and MC2 chimeric subunits contained chicken amino acid sequences from residues 602 to 779 indicates that the epitope for 2A10 does not lie in this region of the molecule.
Interestingly, the integrin activating l'nAb TASC could immunoprecipitate all the chimeric subunits with the exception of MC3. This suggests that the epitope for this mAb resides between amino acids 304 and 602. The epitopes for several other mAbs also mapped to this region of the/~, subunit. These include the mAb "G; which has been previously shown to disrupt or/3 subunit association (Buck et al., 1986) , as well as several mAbs with no known biological activity.
The mAb WIB10 is capable of disrupting cell-substratum adhesion. The epitope for this antibody, however, appears to rest outside the region of the subunit carrying the epitopes for other adhesion-disrupting rnAbs. This mAb immunoprecipitated all the chimeric constructs. The only chicken sequence that is common to all of the chimeric subunits lies between residues 602 and 779. It is reasonable to assume that the antibody cannot react with residues 709 to 779 which include the transmembrane and cytoplasmic domain sequences of the subunit. At least part of the epitope for W1B10 must, therefore, rest between residues 602 and 709. The observation that MC1, MC2, and MC3 resist detachment by the anti-GP140 mammalian ~ antiserum and in particular that MC1 is largely resistant to detachment by the combination of anti-GP140 and CSAT (Fig. 2) , suggest that this polyclonal antibody is reacting primarily against the mouse homologue of the epitope seen by W1B10.
Insertion of Homologous Regions of the Chicken [31 cDNA into the Mouse Subunit Confers Chicken Specific mAb Binding to the Chimeric Subunit
To confirm the location of two regions identified as antibody binding epitopes by the loss-of-binding studies described above, we tested two reciprocal constructs for the acquisition of mAb-binding activity. To accomplish this, we placed the chicken cDNA coding for the CSAT-or TASC-binding domains into the homologous regions of the mouse/~1 subunit. The sequences carrying the epitopes for these mAbs were chosen for two reasons. First, each antibody has distinctly different effects on integrin function. Second, their epitopes mapped to distinct regions of the molecule (i.e., CSAT epitope within the first 160 amino acids; TASC epitope within the cysteine-rich repeats, from amino acids 304 to 602). The two constructs are illustrated in Fig. 4 . As would be predicted, MC4, in which the first 160 mouse sequences were replaced by chicken sequences, reacts with CSAT but not TASC. On the other hand, MC5, in which amino acids 493-779 are chicken, reacted with TASC, but not with CSAT. The fact that TASC did not react with MC3, which contains chicken sequence between amino acids 602 and 779, further limits its epitope to between amino acids 493 and 602. These experiments confirm the location of the epitopes and demonstrate that the loss of rnAb-binding activity in the other chimeric subunits was not caused by secondary structural changes.
Discussion
To facilitate interpretation, the data presented here are schematically summarized in Fig. 5 . The region of the /3, subunit homologous to the suggested ligand-binding domain Figure 4 . CSAT and TASC epitopes can be transferred to mouse /~t eDNA. The regions of chicken/31 cDNA carrying either the CSAT epitope (MC4) or the TASC epitope (MC5) were substituted into the homologous position on mouse 151 cDNA. The resulting constructs were transfected into 3T3 ceils. The transfected cells were biotinylated and extracted as described in Materials and Methods. The extracts were immunoprecipitated with CSAT or TASC as shown in the figure. Antibodies are listed as described in Fig. 3 . In both cases, the substitution of the appropriate chicken sequence resulted in the chimeric subunit being immunoprecipitated by the corresponding mAbs.
of/33 is indicated by shading. A 19-amino acid sequence within this region that is highly conserved among all /3 subunits is depicted as a solid bar. The cysteine residues that are homologous with those cross-linked in the f13 subunit to form two long-range disulfide bonds (Calvete et al., 1991; Beer and Coller, 1989) are connected by lines. These include the first cysteine (C1) occupying position 7 paired with the 16th cysteine (C16) occupying position 445, and the 14th cysteine (C14) at position 415 paired with the 54th cysteine (C54) at position 672. Regions of the subunit bearing the epitopes for the various mAbs investigated here are bracketed by arrows. Numbers of important reference amino acid residues are indicated above the bar.
Integrin-ligand binding and ligand specificity can be altered as a result of long range structural perturbations by antibodies or by intracellular signals (Coller, 1985; Shattil et al., 1985; Brass and Shattil, 1987; O'Toole et al., 1990; Frelinger et al., 1991; Frojmovic et al., 1991; Sims et al., 1991; Chen et al., 1992; discussed in Ginsberg et al., 1992) . The assignment of functional domains to an integrin subunit on the basis of epitope mapping, mutational analysis, deletion analysis or functional analysis of intersubunit chimeras must therefore take into account the possibility that any alterations in integrin function or, in this case, antibody binding, could be the result of secondary changes at other regions of the molecule. We therefore confirmed that the chimeric subunits under investigation here were fully functional and that the interchange of mouse and chicken domains did not, to the best of our knowledge, induce subtle secondary alterations in the structure. The chimeric/~1 subunits paired with subunits, were found on the cell surface, localized in adhesion plaques, and functioned as part of the cell-adhesive mechanism. In addition, the effects of mAb binding on substitution of mouse sequences into homologous regions of the chicken /~ subunit were position specific and reciprocal. tivity, the replacement of the homologous domain of the mouse /5~ subunit with chicken amino acid sequences resulted in the acquisition of antibody reactivity. Because of the apparent structural "plasticity" of integrin subunits, the assignment of functional domains based solely on genetic manipulations may be misleading. Therefore, correlation of genetic analysis with direct chemical or physical determinations of molecular interactions greatly strengthens these structure/function assignments. The assignment of the ligand-binding domain of the /51 subunit within the first 200 amino acid residues is consistent with several lines of evidence derived from independent analyses. Studies in which RGD-containing peptides have been chemically cross-linked to platelet c~libl~3 (D'Souza et al., 1988) and the related vitronectin receptor, c~d53 (Smith and Cheresh, 1988) , have identified a homologous region within the first 250 amino acid residues of the /53 subunit as a ligand-binding domain. Antibodies raised against the highly conserved sequence within this series of amino acid residues (see Fig. 5 ) can block ligand binding (Andrieux et al., 1991) . A single amino acid substitution at position 119 within this region renders a~3 incapable of ligand binding . A similar mutation in the homologous position of the /51 subunit also prevents ligand binding (Takada et al., 1992) .
The epitopes for other adhesion perturbing antibodies, WlB10 and TASC map between residues 493 and the transmembrane domain of the subunit, placing them almost at the opposite end of the extracellular portion of the molecule. Because there are no data implicating this region of any /5 subunit with direct ligand binding, we favor the idea that the activity of these mAbs is the result of their binding to regulatory domains of the subunit. The interaction of mAbs with such domains would change the ligand-binding potential of integrins even though the epitopes for these antibodies reside outside the actual ligand-binding site. In this case, antibody binding would result in the integrin losing its ability to recognize one ligand, and gaining the ability to bind another. This proposal is consistent with what is known concerning the effect of antibodies or ligand binding on the t53 subunit. The binding of mAbs or RGD-containing peptides to the /53 subunit will, by themselves, causes activation of ~b~3 and increased ligand affinity (O'Toole et al., 1990; Frojmovic et al., 1991) . Similar examples of antibodies modifying the activity of integrins carrying the/51 subunit have been documented. One stimulates the binding of c~4/5~ on a myelomonocytic cell line to cells expressing recombinant VCAM-1 (Kovach et al., 1992) . A second induces modification of ligand affinity on the fibronectin receptor o~5/51 (Faull et al., 1993) . A third antibody changes the ligand specificity of a2/3~ to include both collagen and laminin (Chan and Hemler, 1993) . The epitopes for these antibodies have not been identified, but likely reside in domains of the subunit that could be considered regulatory in nature. Assuming the mAb TASC and the ligand blocking rnAb W1B10 define such regulatory domains in the /51 subunit, our data would suggest that these domains will be found in the disulfide-rich region near the transmembrane domain of subunits. Interestingly, the epitope for the mAb G, which dissociates c~//~ heterodimers, also maps to this region of the molecule. This raises the possibility that the ot subunit could influence ligand specificity both by providing part of the structure of the actual Iigand-binding domain (D'Souza et al., 1990) and by causing secondary changes in the/51 subunit through interactions outside the actual ligandbinding site. This might help assure the ligand-binding specificity or affinity of integrins sharing a promiscuous subunit such as Otv, that, depending upon the/3 subunit with which it associates, can bind to one or more ligands.
In summary, the epitope mapping data presented here are consistent with the idea (a) that the ligand-binding domain of the/51 subunit is found within the first 200 amino terminal residues; (b) that there is a regulatory domain located more carboxy terminal between residue 493 and the transmembrane domain; and (c) that o~ subunit interactions may involve sequences also within this regulatory domain.
